Life sciences

Newborn babies to be genetically tested to prevent gentamicin-associated deafness

Around 1,200 babies born in England and Wales each year are at risk of hearing loss from gentamicin.…

Genetic testing reduces adverse drug reactions by nearly a third, major trial results confirm

The 'PREPARE' trial has demonstrated that genetic testing can significantly reduce adverse drug reactions, with the study coordinator stating there is enough evidence to "proceed with implementation".…

Making the case for pharmacogenomics in the management of mental health conditions

A review of the management of mental health conditions and the role of genetics, along with the implementation of pharmacogenomic testing.…

Newborn genome screening: a step too far?

A project to screen the genomes of 100,000 babies for rare diseases is set to begin recruiting in 2023, but it will face ethical and societal challenges.…

Should we be genetic testing before prescribing analgesics?

Managing pain is difficult because there are various factors that can influence how it is perceived, but pharmacogenomic testing may be able to help fine tune pharmaceutical interventions.…

Research, CPD and Learning: 2022 in review

Celebrating the highlights from 2022 and a look ahead to 2023.…

Pharmacy’s link with the natural world

The pick of November's academic papers from Parastou Donyai, chief scientist at the Royal Pharmaceutical Society.…

Pharmacists should be able to refer patients to NHS genomics services, says Royal Pharmaceutical Society

In the Society's consultation response, Thorrun Govind said there needs to be an explanation of how pharmacy staff can enrich and complement the NHS Clinical Genomics Service.…

Royal Pharmaceutical Society and The Pharmaceutical Journal launch prize for early career researchers

The 'Outstanding Pharmacy Early-Career Researcher Award' (OPERA), which will be open to RPS members, was announced at the Society's Celebration of Science event on 10 November 2022.…

Adverse drug reactions reduced by nearly one third after genetic testing, major trial results to show

Exclusive: Ahead of publication of the PREPARE study, the UK trial lead said the results will be "fantastic" news.…